GlassScriptPhysician profile
Jennifer Murray
NPI 1407830896
$13,201.14
in general payments reported to CMS, 2019-2025
32 companies · $2,847 in 2025
The $2,847 reported for 2025 was more than what 91% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,125 · 2020: $814 · 2021: $2,235 · 2022: $1,257 · 2023: $1,240 · 2024: $1,684 · 2025: $2,847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,770.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,705.28 | 2019-2025 | Clareon, Rocklatan, Clareon Panoptix Pro |
| Johnson & Johnson Surgical Vision, INC. | $1,354.07 | 2019-2025 | Tecnis Simplicity, Catalys System, Amo Phaco Needle |
| Glaukos Corporation | $1,287.16 | 2020-2025 | Ce-Marked Kxla System, Kxl System (Not Refurbished), Photrexa Viscous and Photrexa |
| Allergan, INC. | $1,134.75 | 2019-2022 | |
| Abbvie INC. | $985.70 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $742.30 | 2019-2024 | Cequa |
| Bausch & Lomb Americas INC. | $704.80 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $634.74 | 2019-2021 | |
| Horizon Therapeutics Plc | $486.25 | 2019-2023 | Tepezza |
| Aerie Pharmaceuticals, INC. | $296.67 | 2019-2021 | |
| Dompe US, INC. | $283.15 | 2021-2025 | Oxervate |
| Biotissue Holdings INC. | $251.83 | 2025 | |
| Novartis Pharmaceuticals Corporation | $231.02 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $212.83 | 2021-2023 | Acthar |
| Tarsus Pharmaceuticals, INC. | $205.62 | 2025 | Xdemvy |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $101.36 | 2025 | Tepezza |
| Harrow Eye, LLC | $70.23 | 2024-2025 | Iheezo, Tobradex St, Flarex |
| Carl Zeiss Meditec, INC. | $58.44 | 2021 | |
| Shire North American Group INC | $58.07 | 2019 | |
| Eyevance Pharmaceuticals LLC | $55.80 | 2019 | |
| Ani Pharmaceuticals, INC. | $50.13 | 2025 | Iluvien |
| Kala Pharmaceuticals, INC. | $50.08 | 2019 | |
| Eyepoint US, INC. | $42.78 | 2019 | |
| Astellas Pharma US INC | $37.05 | 2025 | Izervay |
| New World Medical,INC. | $33.58 | 2021 | |
| Apellis Pharmaceuticals, INC. | $24.99 | 2025 | Syfovre |
| Mallinckrodt Enterprises LLC | $20.84 | 2019 | |
| Ocular Therapeutix, INC. | $18.14 | 2024 | Dextenza |
| Halozyme INC | $17.21 | 2025 | Hylenex Recombinant |
| Oyster Point Pharma, INC. | $16.88 | 2025 | Tyrvaya |
| Regeneron Healthcare Solutions, INC. | $15.89 | 2025 | Eylea Hd |
| Recordati_rare_diseases_inc. | $13.50 | 2025 | Cystadrops |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.